We are live on ! Find out more
TAK icon

Takeda Pharmaceutical
TAK

298 hedge funds and large institutions have $1.04B invested in Takeda Pharmaceutical in 2021 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 65 increasing their positions, 105 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

407% more call options, than puts

Call options by funds: $60.1M | Put options by funds: $11.9M

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

17% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 52

2% more funds holding

Funds holding: 292 → 298 (+6)

1% less ownership

Funds ownership: 5.81% → 4.81% (-1%)

31% less capital invested

Capital invested by funds: $1.51B → $1.04B (-$465M)

38% less repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 105

Holders
298
Holders Change
+6
Holders Change %
+2.05%
% of All Funds
4.59%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
61
Increased
65
Reduced
105
Closed
52
Calls
$60.1M
Puts
$11.9M
Net Calls
+$48.3M
Net Calls Change
+$4.68M

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$69M
2
BCP
BSN Capital Partners
United Kingdom
+$65.6M
3
Goldman Sachs
Goldman Sachs
New York
+$16.8M
4
HT
HAP Trading
New York
+$9.4M
5
BlackRock
BlackRock
New York
+$5.12M

Top Sellers

Rank Fund Capital Flow
1
GCM
Glenview Capital Management
New York
-$133M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$90.4M
3
AIM
ARK Investment Management
Florida
-$79.1M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$21.3M
5
N
Nuveen
North Carolina
-$18.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
HR
276
Howe & Rusling
New York
$1K – – –
LWA
277
Lenox Wealth Advisors
New York
$1K – – –
TCM
278
Tradewinds Capital Management
Washington
$1K – – –
KSWA
279
Kathleen S. Wright Associates
Pennsylvania
$1K +$912 +65 New
GC
280
Gould Capital
Washington
$1K +$982 +70 New
AIP
281
Ahrens Investment Partners
Louisiana
$1K +$996 +71 New
DHGWA
282
Dixon Hughes Goodman Wealth Advisors
North Carolina
$1K +$1.25K +89 New
EWA
283
EverSource Wealth Advisors
Alabama
$1K +$1.32K +94 New
AAP
284
Arax Advisory Partners
Colorado
$1K +$1.42K +101 New
SFCL
285
Strengthening Families & Communities LLC
Massachusetts
$612 +$11K +782 New
FCT
286
First Community Trust
Iowa
$477 +$491 +35 New
GCM
287
Glenview Capital Management
New York
– -$133M -8,102,119 Closed
T. Rowe Price Associates
288
T. Rowe Price Associates
Maryland
– -$90.4M -5,518,932 Closed
Point72 Asset Management
289
Point72 Asset Management
Connecticut
– -$21.3M -1,299,900 Closed
CIBC Asset Management
290
CIBC Asset Management
Ontario, Canada
– -$5.46M -333,617 Closed
GF
291
Gabelli Funds
New York
– -$4.72M -288,057 Closed
SGI
292
Summit Global Investments
Utah
– -$2.08M -127,237 Closed
CCA
293
Catalyst Capital Advisors
New York
– -$2.06M -126,000 Closed
BRWA
294
B. Riley Wealth Advisors
Florida
– -$1.8M -109,995 Closed
AC
295
Avestar Capital
New York
– -$984K -60,046 Closed
SW
296
SVB Wealth
Massachusetts
– -$900K -54,985 Closed
TD Asset Management
297
TD Asset Management
Ontario, Canada
– -$782K -47,760 Closed
CQS
298
Credential Qtrade Securities
– -$750K -45,760 Closed
Simplex Trading
299
Simplex Trading
Illinois
– -$399K -28,449 Closed
BHA
300
Beech Hill Advisors
New York
– -$426K -26,000 Closed
10 11
12
13 14

TAK Hedge Fund Activity: Q4 2021 in Review

298 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Takeda Pharmaceutical (TAK) for Q4 2021, worth a combined $1.04B — down 31% from $1.51B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new TAK positions and 52 closed out — a net gain of 9 holders — while 65 added to existing stakes and 105 trimmed.

The largest buyer was Citigroup, adding an estimated $69M. The largest seller was Glenview Capital Management, exiting entirely with an estimated $133M sold.

  • 298 institutional investors held Takeda Pharmaceutical (TAK) as of Q4 2021, up from 292 in Q3 2021.
  • Funds reported $1.04B of Takeda Pharmaceutical stock for Q4 2021, down 31% quarter-over-quarter.
  • 61 funds opened new Takeda Pharmaceutical positions in Q4 2021 and 52 closed out, a net change of +9 holders.
  • The largest Takeda Pharmaceutical buyer in Q4 2021 was Citigroup, an estimated $69M added.
  • The largest Takeda Pharmaceutical seller in Q4 2021 was Glenview Capital Management, an estimated $133M sold.

Based on aggregated 13F filings for Q4 2021.